GLP-1 receptor agonist medications have shown average weight loss of 15-22% in recent clinical trials, making them a powerful tool for sustainable weight management
Sarcopenia (muscle loss) due to rapid weight loss if measures to preserve muscle are not taken, including regular strength training, staying active, and eating a protein-rich diet
Explore recent launches: This January 2024, Eli Lilly launched the direct-to-consumer service LillyDirect for obesity, insulin, and migraine medication
This can allow you to predict your cycle more accurately and confer other health benefits
N., Robinson, S., Kennedy-Martin, T., Poon, J
Are there specific NHS criteria for weight loss surgery in the UK